A.R.T. Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,200
Closed -$478K 71
2020
Q4
$478K Buy
+8,200
New +$495K 2.21% 13
2020
Q1
Sell
-145,900
Closed -$9.48M 418
2019
Q4
$9.48M Buy
+145,900
New +$9.5M 0.47% 20
2019
Q2
Sell
-122,700
Closed -$7.98M 1457
2019
Q1
$7.98M Buy
122,700
+84,000
+217% +$5.58M 0.48% 20
2018
Q4
$2.42M Sell
38,700
-41,300
-52% -$2.89M 0.16% 183
2018
Q3
$6.18M Buy
+80,000
New +$6.04M 0.28% 66
2017
Q1
Sell
-73,400
Closed -$5.26M 1516
2016
Q4
$5.26M Buy
+73,400
New +$5.46M 0.31% 51
2016
Q2
Sell
-38,962
Closed -$3.58M 1460
2016
Q1
$3.58M Sell
38,962
-125,500
-76% -$11.3M 0.16% 176
2015
Q4
$16.6M Buy
164,462
+6,011
+4% +$625K 0.79% 3
2015
Q3
$15.6M Buy
158,451
+135,230
+582% +$15M 0.58% 18
2015
Q2
$2.72M Sell
23,221
-104,652
-82% -$11.4M 0.09% 343
2015
Q1
$12.5M Buy
+127,873
New +$13M 0.43% 23
2014
Q3
Sell
-93,792
Closed -$7.78M 1383
2014
Q2
$7.78M Buy
93,792
+79,994
+580% +$6.23M 0.4% 30
2014
Q1
$977K Sell
13,798
-81,055
-85% -$6.36M 0.05% 511
2013
Q4
$7.12M Buy
94,853
+30,952
+48% +$2.16M 0.38% 37
2013
Q3
$4.01M Buy
63,901
+50,380
+373% +$3.01M 0.22% 110
2013
Q2
$693K Buy
+13,521
New +$705K 0.02% 759

Other funds holding GILD

A.R.T. Advisors's GILD Position: Q1 2021 in Review

A.R.T. Advisors sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 8,200 shares — an estimated $478K sold.

A.R.T. Advisors first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $16.6M in Q4 2015. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • A.R.T. Advisors reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 8,200 Gilead Sciences shares in Q1 2021, an estimated $478K.
  • A.R.T. Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
  • A.R.T. Advisors's Gilead Sciences position peaked at $16.6M in Q4 2015.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on A.R.T. Advisors's 13F filing for Q1 2021, filed 17 May 2021.